Applications of hematopoietic stem cells and gene transfer.

R Huss
{"title":"Applications of hematopoietic stem cells and gene transfer.","authors":"R Huss","doi":"10.1159/000223285","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In this review, the hematopoietic stem cell is defined and the change of this definition over the past decades is elucidated. Besides we discuss how the applications of stem cell transplantation have changed in the same period of time. In addition to the biology of hematopoietic stem cells, the most recent applications in gene transfer and gene therapy will be discussed.</p><p><strong>Data sources: </strong>Review of the literature and results of studies performed at the Fred Hutchison Cancer Research Center in Seattle, USA.</p><p><strong>Selection criteria: </strong>Peer review journals and papers relevant to the topic.</p><p><strong>Results: </strong>Based on the initial radiation experiments in mice, the hematopoietic stem cell was defined by its biological properties and later by the expression of certain surface antigens, as well as the absence of lineage-specific markers. Quite recently, more and more evidence has emerged that hematopoietic stem cells can be isolated from peripheral blood and that there might be a common progenitor of hematopoiesis and the marrow microenvironment. Hematopoietic stem cells are also a useful aid for gene therapy in a broader range of immunodeficiencies and metabolic disorders.</p><p><strong>Conclusions: </strong>Peripheral blood stem cells transplantation and gene therapy will be useful tools to treat a broader spectrum of diseases using uncommitted very early progenitor cells isolated from peripheral blood.</p>","PeriodicalId":13632,"journal":{"name":"Infusionstherapie und Transfusionsmedizin","volume":"23 3","pages":"147-60"},"PeriodicalIF":0.0000,"publicationDate":"1996-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000223285","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infusionstherapie und Transfusionsmedizin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000223285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: In this review, the hematopoietic stem cell is defined and the change of this definition over the past decades is elucidated. Besides we discuss how the applications of stem cell transplantation have changed in the same period of time. In addition to the biology of hematopoietic stem cells, the most recent applications in gene transfer and gene therapy will be discussed.

Data sources: Review of the literature and results of studies performed at the Fred Hutchison Cancer Research Center in Seattle, USA.

Selection criteria: Peer review journals and papers relevant to the topic.

Results: Based on the initial radiation experiments in mice, the hematopoietic stem cell was defined by its biological properties and later by the expression of certain surface antigens, as well as the absence of lineage-specific markers. Quite recently, more and more evidence has emerged that hematopoietic stem cells can be isolated from peripheral blood and that there might be a common progenitor of hematopoiesis and the marrow microenvironment. Hematopoietic stem cells are also a useful aid for gene therapy in a broader range of immunodeficiencies and metabolic disorders.

Conclusions: Peripheral blood stem cells transplantation and gene therapy will be useful tools to treat a broader spectrum of diseases using uncommitted very early progenitor cells isolated from peripheral blood.

造血干细胞与基因转移的应用。
目的:本文综述了造血干细胞的定义,并对近几十年来造血干细胞定义的变化进行了阐述。此外,我们还讨论了干细胞移植的应用在同一时期的变化。除了造血干细胞的生物学,最新的应用在基因转移和基因治疗将被讨论。资料来源:美国西雅图Fred Hutchison癌症研究中心的文献和研究结果综述。入选标准:同行评议的与主题相关的期刊和论文。结果:基于小鼠的初始辐射实验,造血干细胞由其生物学特性定义,后来通过表达某些表面抗原以及缺乏谱系特异性标记来定义。近年来,越来越多的证据表明造血干细胞可以从外周血中分离出来,造血干细胞与骨髓微环境可能存在共同的祖细胞。造血干细胞在更广泛的免疫缺陷和代谢紊乱的基因治疗中也是一个有用的辅助工具。结论:外周血干细胞移植和基因治疗将是使用从外周血中分离的未固定的非常早期祖细胞治疗更广泛疾病的有用工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信